The Association between Chronic Obstructive Pulmonary Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography

References

• Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J. 2012;6(4):208–14.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608.
   PubMed Web of Science ®Google Scholar
• Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46(4):517–92.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. Respir Care. 2002;47(10):1184–99.
   PubMedGoogle Scholar
• Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220.
   PubMed Web of Science ®Google Scholar
• Campo G, Pavasini R, Malagu M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015;29(2):147–57. doi:10.1007/s10557-014-6569-y.
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–35. doi:10.1164/rccm.201209-1665OC.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Morimoto T, Furukawa Y, Nakagawa Y, Ehara N, Taniguchi R, Ozasa N, Saito N, Hoshino K, Touma M. Chronic obstructive pulmonary disease-an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease. Int J Cardiol. 2010;143(2):178–83.
   PubMed Web of Science ®Google Scholar
• Rasmussen T, Køber L, Pedersen JH, Dirksen A, Thomsen LH, Stender S, Brodersen J, Groen J, Ashraf H, Kofoed KF. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers. Eur Heart J Cardiovasc Imaging. 2013;14(12):1159–66. doi:10.1093/ehjci/jet057.
   PubMed Web of Science ®Google Scholar
• Topsakal R, Kalay N, Ozdogru I, Cetinkaya Y, Oymak S, Kaya MG, Dogan A, Inanc MT, Ergin A. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels. 2009;24(3):164–8. doi:10.1007/s00380-008-1103-4.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163–78. doi:10.1378/chest.12-2847.
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Martinez A, Guzman E, de Lucas P, Rodriguez JM. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulmon Dis. 2010;5:387–94.
   PubMedGoogle Scholar
• Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015;169(6):833–40. doi:10.1016/j.ahj.2015.02.022.
   PubMed Web of Science ®Google Scholar
• Kaila KS, Norris CM, Graham MM, Ali I, Bainey KR. Long-term survival with revascularization in South Asians admitted with an acute coronary syndrome (from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease Registry). Am J Cardiol. 2014;114(3):395–400. doi:10.1016/j.amjcard.2014.04.051.
   PubMed Web of Science ®Google Scholar
• Bresee LC, Knudtson ML, Zhang J, et al. Likelihood of coronary angiography among First Nations patients with acute myocardial infarction. CMAJ. 2014;186(10):E372–80. doi:10.1503/cmaj.131667.
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Saunders LD, Parsons GA, Nilsson CI, Alibhai A, Ghali WA. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43(4):1424–41. doi:10.1111/j.1475-6773.2007.00822.x.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, Wang X, Austin PC, O'Donnell DE, Aaron SD, To TM, Gershon AS. Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease. Br J Clin Pharmacol. 2018;84(3):579–89.
   PubMed Web of Science ®Google Scholar
• McGuire K, Avina-Zubieta JA, Esdaile JM, Sadatsafavi M, Sayre EC, Abrahamowicz M, Lacaille D. Risk of incident chronic obstructive pulmonary disease (COPD) in rheumatoid arthritis: a population based cohort study. Arthritis Care Res (Hoboken). 2017. doi:10.1002/acr.23410. [Epub ahead of print]
   Google Scholar
• Lee TM, Tu K, Wing LL, Gershon AS. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study. NPJ Prim Care Respir Med. 2017;27(1):34.
   PubMed Web of Science ®Google Scholar
• Fodor JG, Frohlich JJ, Genest JJ, McPherson PR. Recommendations for the management and treatment of dyslipidemia Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Can Med Assoc J. 2000;162(10):1441–7.
   Web of Science ®Google Scholar
• Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, Floras JS, Haynes RB, Honos G, Leenen FH. 1999 Canadian recommendations for the management of hypertension. Can Med Assoc J. 1999;161(12 suppl):S1–S17.
   Web of Science ®Google Scholar
• Lochner KA, Goodman RA, Posner S, Parekh A. Multiple chronic conditions among Medicare beneficiaries: state-level variations in prevalence, utilization, and cost, 2011. Medicare Medicaid Res Rev. 2013;3(3).
   PubMedGoogle Scholar
• Arnett DK, Goodman RA, Halperin JL, Anderson JL, Parekh AK, Zoghbi WA. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. J Am Coll Cardiol. 2014;64(17):1851–6. doi:10.1016/j.jacc.2014.07.012.
   PubMed Web of Science ®Google Scholar
• Koseoglu C, Kurmus O, Ertem AG, Colak B, Bilen E, Ipek G, Durmaz T, Keles T, Bozkurt E. Association between carotid intima-media thickness and presence of coronary artery disease in chronic obstructive pulmonary disease patients. Anatol J Cardiol. 2016;16(8):601–7.
   PubMed Web of Science ®Google Scholar
• Almagro P, Lapuente A, Pareja J, Yun S, Garcia ME, Padilla F, Heredia JL, De la Sierra A, Soriano JB. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:1353.
   PubMed Web of Science ®Google Scholar
• Liang B, Xu Z, Yi Q, Ou X, Feng Y. Association of chronic obstructive pulmonary disease with coronary artery disease. Chin Med J. 2012;126(17):3205–8.
   Web of Science ®Google Scholar
• Sin DD, Man SP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? Circulation. 2003;107(11):1514–9. doi:10.1161/01.CIR.0000056767.69054.B3.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, Cooper JA Jr, Curtis JL, Dransfield MT, Han MK. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med. 2014;370(23):2201–10.
   PubMed Web of Science ®Google Scholar
• Chen CY, Holbrook M, Duess MA, Dohadwala MM, Hamburg NM, Asztalos BF, Milbury PE, Blumberg JB, Vita JA. Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial. Nutr J. 2015;14:61.
   PubMed Web of Science ®Google Scholar
• Akodad M, Lattuca B, Nagot N, et al. COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. Arch Cardiovasc Dis. 2017;110(6–7):395–402. doi:10.1016/j.acvd.2016.10.004.
   PubMed Web of Science ®Google Scholar
• Liang Y, Li YP, He F, Liu XQ, Zhang JY. Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease. Braz J Med Biol Res. 2015;48(6):568–76. doi:10.1590/1414-431X20144452.
   PubMed Web of Science ®Google Scholar
• Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F. Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Basic Res Cardiol. 2015;110(2):11.
   PubMed Web of Science ®Google Scholar
• Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–81. doi:10.1164/rccm.201207-1299OC.
   PubMed Web of Science ®Google Scholar
• Culver BH. How should the lower limit of the normal range be defined? Respir Care. 2012;57(1):136–45; discussion 43–5.
   PubMed Web of Science ®Google Scholar
• Miller MR, Levy ML. Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ. 2015;351:h3021.
   PubMedGoogle Scholar
• Miller MR, Haroon S, Jordan RE, Sitch AJ, Dickens AP, Enocson A, Fitzmaurice DA, Adab P. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial. Int J Chron Obstruct Pulmon Dis. 2018;13:1979–86. doi:10.2147/COPD.S146914.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.
   PubMed Web of Science ®Google Scholar